Is Edwards Lifesciences stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Edwards Lifesciences 10 years ago, but if you had invested on Wednesday 23rd of February 2022 when the price was CHF188.26, you would have made a loss of CHF0.000 per share or 0.00%
We do not have enough data to give you this answer.
Edwards Lifesciences has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 1.00, the company's ability to pay off the debt is good. Edwards Lifesciences has a very good net profit margin of 23.37% and should have very high tolerances against inflation.
We have calculated the inflation risk for Edwards Lifesciences to be low [0 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.